AC

Agati Capital

Description

Agati Capital is an investment firm.

Investor Profile

Agati Capital has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • Australia (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Agati Capital frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Uniseed
Oceania, Queensland, Australia, Brisbane
Co-Investments: 1
Breakthrough Victoria
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1
UniSuper
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1

What are some of recent deals done by Agati Capital?

Aravax

Melbourne, Victoria, Australia

Aravax is an early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy.

BiotechnologyHealth CareWellness
Series BJan 23, 2024
Amount Raised: $22,200,000